268 related articles for article (PubMed ID: 17224327)
1. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
[TBL] [Abstract][Full Text] [Related]
2. Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy.
Ito T; Tanimoto M; Yamada K; Kaneko S; Matsumoto M; Obayashi K; Hagiwara S; Murakoshi M; Aoki T; Wakabayashi M; Gohda T; Funabiki K; Maeda K; Horikoshi S; Tomino Y
Nephrology (Carlton); 2006 Feb; 11(1):29-35. PubMed ID: 16509929
[TBL] [Abstract][Full Text] [Related]
3. Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice.
Hagiwara S; Gohda T; Tanimoto M; Ito T; Murakoshi M; Ohara I; Yamazaki T; Matsumoto M; Horikoshi S; Funabiki K; Tomino Y
Metabolism; 2009 Jul; 58(7):934-45. PubMed ID: 19427656
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-Ay/Ta mice.
Murakoshi M; Tanimoto M; Gohda T; Hagiwara S; Ohara I; Toyoda H; Ishikawa Y; Horikoshi S; Tomino Y
Diabetes Res Clin Pract; 2009 Feb; 83(2):183-9. PubMed ID: 19144436
[TBL] [Abstract][Full Text] [Related]
5. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.
Zhang M; Hagiwara S; Matsumoto M; Gu L; Tanimoto M; Nakamura S; Kaneko S; Gohda T; Qian J; Horikoshi S; Tomino Y
Metabolism; 2006 Dec; 55(12):1590-8. PubMed ID: 17142129
[TBL] [Abstract][Full Text] [Related]
6. Pyridoxal phosphate prevents progression of diabetic nephropathy.
Nakamura S; Li H; Adijiang A; Pischetsrieder M; Niwa T
Nephrol Dial Transplant; 2007 Aug; 22(8):2165-74. PubMed ID: 17449494
[TBL] [Abstract][Full Text] [Related]
7. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
8. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
[TBL] [Abstract][Full Text] [Related]
9. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.
Fan Q; Liao J; Kobayashi M; Yamashita M; Gu L; Gohda T; Suzuki Y; Wang LN; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2004 Dec; 19(12):3012-20. PubMed ID: 15574998
[TBL] [Abstract][Full Text] [Related]
10. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
11. Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.
Williams ME; Bolton WK; Khalifah RG; Degenhardt TP; Schotzinger RJ; McGill JB
Am J Nephrol; 2007; 27(6):605-14. PubMed ID: 17823506
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycemic effect of hot-water extract of adzuki (Vigna angularis) in spontaneously diabetic KK-A(y) mice.
Itoh T; Kobayashi M; Horio F; Furuichi Y
Nutrition; 2009 Feb; 25(2):134-41. PubMed ID: 18929464
[TBL] [Abstract][Full Text] [Related]
13. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
14. Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy.
Elseweidy MM; Elswefy SE; Younis NN; Zaghloul MS
Exp Biol Med (Maywood); 2013 Aug; 238(8):881-8. PubMed ID: 23970406
[TBL] [Abstract][Full Text] [Related]
15. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H
J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
[TBL] [Abstract][Full Text] [Related]
16. Effect of pitavastatin on type 2 diabetes mellitus nephropathy in KK-Ay/Ta mice.
Matsumoto M; Tanimoto M; Gohda T; Aoki T; Murakoshi M; Yamada K; Yamazaki T; Kaneko S; Horikoshi S; Tomino Y
Metabolism; 2008 May; 57(5):691-7. PubMed ID: 18442635
[TBL] [Abstract][Full Text] [Related]
17. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Sohn EJ; Kim CS; Kim YS; Jung DH; Jang DS; Lee YM; Kim JS
Life Sci; 2007 Jan; 80(5):468-75. PubMed ID: 17070554
[TBL] [Abstract][Full Text] [Related]
18. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
19. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
[TBL] [Abstract][Full Text] [Related]
20. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.
Figarola JL; Scott S; Loera S; Xi B; Synold T; Weiss L; Rahbar S
Diabetes Metab Res Rev; 2005; 21(6):533-44. PubMed ID: 15818713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
